Dan Laser, Myka Labs CEO. A highly accomplished life sciences leader, Dan comes to Myka Labs from Applaud, where, as founding CEO, he led the company’s successful development of the first lipid nanoparticle-based products incorporating alendronate chemistry for treating biomineralization-associated conditions in the urinary tract and vasculature. He also served as CEO at specialty bioassay research firm Wave 80, where he led the organization in developing innovative new assays for use in clinical research and patient care in high-unmet-need diseases including HIV/AIDS, tuberculosis and type 1 diabetes. Earlier in his career, Dan worked on input device haptic feedback systems and on computer vision algorithm development for surgical robots. He holds Ph.D. and masters degrees from Stanford University in mechanical engineering and undergraduate degrees in mechanical engineering and political science from Northwestern.
Mike Harrison, MD, Myka Labs Chief Scientific Officer. Over the course of a long and distinguished career at the University of California at San Francisco, Mike was the driving force behind innumerable advances in pediatric and fetal surgery. Based on a unique understanding of gastrointestinal tract physiology gained through his experience performing innumerable surgical repairs of conditions like congenital esophageal atresia, Mike developed a compelling vision for innovative new endoluminal approaches to GI tract interventions–a vision that is at the heart of the Myka Labs product pipeline. Mike was the founder of the International Fetal Medicine Surgery Society (IFMSS) and has authored more than four hundred peer-reviewed articles and several textbooks.
Lee Swanstrom, MD, Myka Labs Chief Medical Officer. A pre-eminent innovator in endoscopy and minimally invasive surgical systems and methods, Lee is past president of both the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the Foundation for Surgical Innovation and Education. He has authored of over 350 peer-reviewed articles and multiple textbooks including a leading text on endoscopic and laparoscopic surgery. In addition to his role at Myka Labs, Lee was previously Chief Innovation Officer at the Institute of Image-Guided Surgery in Strasbourg, France.
Clinical Advisory Board
Dr. Deborah Nagle, Chief, Colon and Rectal Surgery, Stony BrookDr. Miguel Burch, Director, Division of General Surgery, Cedars-SinaiDr. Edward Benz, Harvard University/CEO Emeritus, Dana-Farber Cancer InstituteDr. Rich Isaacs, Dean, California Northstate University College of MedicineDr. Brett Sheppard, Oregon Health Sciences, Co-Director, Brenden-Colson Center for Pancreatic CareDr. Marshall Stoller, Vice Chair, Urology, UCSFJoo Ha Hwang, Interventional Gastroenterology, StanfordDr. Barry Salky, General Surgery, Mount Sinai
